Glassman Wealth Services’s Integra LifeSciences IART Stock Holding History

Glassman Wealth Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5	Closed	-$191	–	2022
2023 Q3	$191	Hold	5	–	–	﹤0.01%	1895
2023 Q2	$206	Hold	5	–	–	﹤0.01%	1806
2023 Q1	$287	Hold	5	–	–	﹤0.01%	1721
2022 Q4	$280	Hold	5	–	–	﹤0.01%	1724
2022 Q3	$0	Hold	5	–	–	﹤0.01%	1813
2022 Q2	$0	Sell	5 -35	-88%	-$2.1K	﹤0.01%	1821
2022 Q1	$3K	Hold	40	–	–	﹤0.01%	1138
2021 Q4	$3K	Buy	40 +35	+700%	+$2.37K	﹤0.01%	1106
2021 Q3	$0	Hold	5	–	–	﹤0.01%	1695
2021 Q2	$0	Hold	5	–	–	﹤0.01%	1549
2021 Q1	$0	Hold	5	–	–	﹤0.01%	1510
2020 Q4	$0	Hold	5	–	–	﹤0.01%	1434
2020 Q3	$0	Hold	5	–	–	﹤0.01%	1405
2020 Q2	$0	Hold	5	–	–	﹤0.01%	1365
2020 Q1	$0	Buy	+5	New	+$262	﹤0.01%	1320

Other funds holding IART

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glassman Wealth Services's IART Position: Q4 2023 in Review

Glassman Wealth Services sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 5 shares — an estimated $191 sold.

Glassman Wealth Services first reported a position in IART in Q1 2020 and held it in 15 quarters. The position peaked at $3K in Q1 2022. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

Glassman Wealth Services reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
Glassman Wealth Services sold 5 Integra LifeSciences shares in Q4 2023, an estimated $191.
Glassman Wealth Services first reported a position in Integra LifeSciences in Q1 2020 and held it in 15 quarters.
Glassman Wealth Services's Integra LifeSciences position peaked at $3K in Q1 2022.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on Glassman Wealth Services's 13F filing for Q4 2023, filed 12 Feb 2024.